4.65
price up icon80.23%   2.07
pre-market  Pre-market:  4.07   -0.58   -12.47%
loading

Lipella Pharmaceuticals Inc Stock (LIPO) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
0.1459
- - - 0.118
Operating Expenses
1.3635
- - - 1.2025
Benefits Costs and Expenses
1.3377
- - - 1.1859
Costs And Expenses
1.3377
- - - 1.1859
Operating Income/Loss
66.89%
-1.2176
-0.7296 -1.3567 -1.5752 -1.0844
Nonoperating Income/Loss
36.53%
0.0258
0.0407 0.0332 0.0365 0.0166
Income/Loss From Continuing Operations Before Tax
73.01%
-1.1918
-0.6889 -1.3236 -1.5387 -1.0678
Income/Loss From Continuing Operations After Tax
73.01%
-1.1918
-0.6889 -1.3236 -1.5387 -1.0678
Net Income/Loss
73.01%
-1.1918
-0.6889 -1.3236 -1.5387 -1.0678
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,750%
7.2924
0.2558 5.7537 5.7439 5.7439
Diluted Average Shares
2,750%
7.2924
0.2558 5.7537 5.7439 5.7439
Basic Earnings Per Share
77.78%
-0.16
-0.09 -0.23 -0.27 -0.19
Diluted Earnings Per Share
77.78%
-0.16
-0.09 -0.23 -0.27 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):